Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimada

Showing results (331-340 of 360) with videos related to

Pageof 36
Sort By:
International Journal of Hematology|September 27, 2013
Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study GroupDaisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working GroupAkihito Shinohara, Kumi Oshima, Shigeo Fuji, et al.
Pediatric Blood & Cancer|September 5, 2020
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)Daiichiro Hasegawa, Akio Tawa, Daisuke Tomizawa, et al.
Pediatric Blood & Cancer|October 21, 2015
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Tomoyuki Watanabe, Daisuke Tomizawa, et al.
Haematologica|March 18, 2021
Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemiaTaeko Kaburagi, Genki Yamato, Norio Shiba, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)Kohjiro Ueki, Yukio Tanizawa, Jiro Nakamura, et al.
Haematologica|July 13, 2014
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemiaHidemasa Matsuo, Mio Kajihara, Daisuke Tomizawa, et al.
Diabetology International|January 29, 2025
Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trialNaoki Sakane, Munehide Matsuhisa, Akio Kuroda, et al.
Plos One|April 25, 2014
Distinct cell clusters touching islet cells induce islet cell replication in association with over-expression of Regenerating Gene (REG) protein in fulminant type 1 diabetesKaoru Aida, Sei Saitoh, Yoriko Nishida, et al.
Blood Advances|January 10, 2022
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemiaGenki Yamato, Tomoko Kawai, Norio Shiba, et al.
Pageof 36

Showing results (331-340 of 360) with videos related to

Sort By:
Pageof 36
International Journal of Hematology|September 27, 2013
Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study GroupDaisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2019
Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working GroupAkihito Shinohara, Kumi Oshima, Shigeo Fuji, et al.
Pediatric Blood & Cancer|September 5, 2020
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)Daiichiro Hasegawa, Akio Tawa, Daisuke Tomizawa, et al.
Pediatric Blood & Cancer|October 21, 2015
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Tomoyuki Watanabe, Daisuke Tomizawa, et al.
Haematologica|March 18, 2021
Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemiaTaeko Kaburagi, Genki Yamato, Norio Shiba, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)Kohjiro Ueki, Yukio Tanizawa, Jiro Nakamura, et al.
Haematologica|July 13, 2014
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemiaHidemasa Matsuo, Mio Kajihara, Daisuke Tomizawa, et al.
Diabetology International|January 29, 2025
Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trialNaoki Sakane, Munehide Matsuhisa, Akio Kuroda, et al.
Plos One|April 25, 2014
Distinct cell clusters touching islet cells induce islet cell replication in association with over-expression of Regenerating Gene (REG) protein in fulminant type 1 diabetesKaoru Aida, Sei Saitoh, Yoriko Nishida, et al.
Blood Advances|January 10, 2022
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemiaGenki Yamato, Tomoko Kawai, Norio Shiba, et al.
Pageof 36